pyrroles has been researched along with Barrett Epithelium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, K; Cheng, E; Genta, RM; Hatanpaa, KJ; Huo, X; Melton, S; Peng, S; Pham, TH; Rezai, D; Sarode, V; Souza, RF; Spechler, SJ; Wang, DH; Wright, E; Xu, H; Yu, C; Zhang, Q; Zhang, X | 1 |
| Bruns, CJ; Guba, M; Jauch, KW; Kleespies, A | 1 |
1 review(s) available for pyrroles and Barrett Epithelium
| Article | Year |
|---|---|
Vascular endothelial growth factor in esophageal cancer.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Barrett Esophagus; Bevacizumab; Carcinoma, Squamous Cell; Esophageal Neoplasms; Humans; Indoles; Lymphangiogenesis; Neovascularization, Pathologic; Oxindoles; Prognosis; Propionates; Protein-Tyrosine Kinases; Pyrroles; RNA, Catalytic; RNA, Messenger; Vascular Endothelial Growth Factor A | 2004 |
1 other study(ies) available for pyrroles and Barrett Epithelium
| Article | Year |
|---|---|
Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Autocrine Communication; Barrett Esophagus; Biomarkers; Biomarkers, Tumor; Cell Line; Cell Proliferation; Esophageal Neoplasms; Female; Humans; Immunohistochemistry; Indoles; MAP Kinase Signaling System; Mice; Phospholipase C gamma; Phosphorylation; Precancerous Conditions; Protein Kinase C; Pyrroles; Real-Time Polymerase Chain Reaction; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2014 |